BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Doxorubicin
,
rs3825942
,
FGF21
,
Angiogenesis
,
Obesity
,
Breast
,
Laryngoscope
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
LU 1
Summary
General Info
Curated Studies
Most Correlated Studies
Small cell and non-small cell lung cancer cell lines profiled by histology, gender, and ancestry
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
Lung cancer cells treated with ARS-1620 compound or with trametinib
Explore Curated Studies Results
Literature
Most Relevant Literature
Removal of mercury ions from aqueous by functionalized LUS-1 with Bis [3-(triethoxysilyl) propyl] te…
Introducing Lu-1, a Novel Lactobacillus jensenii Phage Abundant in the Urogenital Tract.
Five undescribed aryltetralin lignans with cytotoxic activities from the fruits of Cleistanthus eber…
Radiolabelled 177 Lu-Bispidine-Trastuzumab for Targeting Human Epidermal Growth Factor Receptor 2 Po…
Theranostic Agent Targeting Bone Metastasis: A Novel [68Ga]Ga/[177Lu]Lu-DOTA-HBED-bisphosphonate.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
FAPi Radioligand OpeN-Label, Phase 1 Study to Evaluate Safety, Tolerability and DosImetry of [Lu-177…
A Study of Lu AF82422 in Participants With Multiple System Atrophy
A Study to Evaluate a New Tablet Formulation of Lu AG06466 in Healthy Participants
Safety and Tolerability Study of Lu AG06466 in Healthy Young Japanese and Caucasian Participants
A Study Investigating Lu AG22515 in Healthy Adults
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ